GlassScriptPhysician profile
Karla D Gorio
NPI 1750613345
$8,658.80
in general payments reported to CMS, 2019-2025
38 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 85% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $822 · 2022: $2,251 · 2023: $2,652 · 2024: $1,605 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,697 · Travel and Lodging: $889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,696.93 |
| Travel and Lodging | $888.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,620.67 | 2022-2025 | Cardiomems, Jot Dx, Gallant |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $798.60 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $623.76 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $518.08 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $501.05 | 2021-2025 | Verquvo |
| Amgen INC. | $322.58 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $301.53 | 2021-2025 | |
| Esperion Therapeutics, INC. | $291.47 | 2021-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $280.16 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $271.09 | 2021-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $267.97 | 2021-2025 | Camzyos |
| Amarin Pharma, INC. | $243.85 | 2021-2022 | |
| Inari Medical, INC. | $208.05 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Daiichi Sankyo INC. | $200.32 | 2021-2023 | Injectafer |
| Sanofi-Aventis U.S. LLC | $166.22 | 2021-2024 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $156.22 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $133.64 | 2021-2024 | Farxiga, Andexxa |
| Novo Nordisk INC | $129.95 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic, INC. | $76.42 | 2023-2024 | Linq II |
| Boston Scientific Corporation | $74.21 | 2021-2025 | Emblem Mri S-Icd, Watchman Flx |
| Itamar Medical INC | $61.31 | 2023-2024 | Watchpatone |
| Kiniksa Pharmaceuticals, LTD. | $47.79 | 2021-2023 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $41.94 | 2022-2025 | Opsynvi |
| Regeneron Healthcare Solutions, INC. | $40.38 | 2025 | Evkeeza |
| Cvrx, INC. | $34.06 | 2023 | Barostim Neo System |
| Mannkind Corporation | $26.64 | 2025 | |
| Edwards Lifesciences Corporation | $25.37 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Stryker Corporation | $24.25 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astellas Pharma US INC | $23.15 | 2022 | |
| Philips North America LLC | $20.21 | 2024 | (Ck4) Mcot |
| Lexicon Pharmaceuticals, INC. | $17.13 | 2023 | Inpefa |
| Biogen, INC. | $16.99 | 2024 | Skyclarys |
| Glaxosmithkline, LLC. | $16.86 | 2025 | Shingrix |
| Impulse Dynamics (USA) INC. | $16.29 | 2022 | |
| Abiomed | $15.82 | 2024 | Impella |
| Inspire Medical Systems, INC. | $15.48 | 2025 | Inspire |
| Lilly USA, LLC | $14.98 | 2025 | Mounjaro, Zepbound |
| Kestra Medical Technology Services, INC. | $14.31 | 2023 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karla Gorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.